Terumo Aortic announces launch and first commercial use of Aortic Balloon device

2923

Terumo Aortic has announced the launch and first commercial case of the Aortic Balloon in the USA. The device assists physicians in the expansion of the aorta when using Treo and Relay stent grafts in endovascular aortic repair, a press release details.

According to the company, the low-profile Aortic Balloon is a 10Fr device offering inflation control and a broad balloon diameter range, up to 50mm.

The first commercial use of the product was undertaken by Siddharth Patel, vascular surgeon, Northside Vascular Surgery, Atlanta, USA, during an implantation of a Treo abdominal stent graft. Patel commented: “The Aortic Balloon performed very well, with good inflation control, and rapid inflation and deflation. Also, its low profile gave me the ability to utilise the 13Fr leg extension detachable sheath of Treo for stent graft remodelling without exchanging sheaths.”

Paul Kuznik, president of Terumo Aortic North America commented: “We are delighted to bring this low-profile balloon to the market and strengthen our credentials as a one-stop shop for aortic solutions.”


LEAVE A REPLY

Please enter your comment!
Please enter your name here